☆ 4.6 Article

High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity

FRONTIERS IN ONCOLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Oncology

TGFβ biology in cancer progression and immunotherapy

Rik Derynck et al.

Summary: TGF beta signaling plays a key role in cancer progression by promoting cancer cell invasion, dissemination, stem cell properties, therapeutic resistance, and the generation of an immunosuppressive environment. Inhibiting TGF beta signaling is considered a crucial avenue to enhance the efficacy of cancer immunotherapies. Understanding and targeting TGF beta signaling mechanisms in tumors and their microenvironment may provide valuable insights for cancer treatment.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Add to Collection

Review Oncology

TGF-β in Cancer: Metabolic Driver of the Tolerogenic Crosstalk in the Tumor Microenvironment

Roberta Angioni et al.

Summary: Metabolic reprogramming in the tumor microenvironment is crucial for cancer progression and metastasis, with TGF-beta playing a central role in driving immune suppression and tolerogenic cell accumulation.

CANCERS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Xiaoqi Mao et al.

Summary: CAFs, as a crucial component of TME, play significant roles in promoting tumor growth, invasion, and metastasis. The interaction between CAFs and tumor cells, as well as immune cells in TIME, is critical for tumor progression.

MOLECULAR CANCER (2021)

Add to Collection

Review Oncology

Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes

Yijun Wang et al.

Summary: Myeloid-derived suppressor cells (MDSCs) hinder T cell infiltration into tumor sites, restricting the effectiveness of immune checkpoint inhibitors for certain patients, while targeting MDSCs has shown potent inhibitory effects in multiple tumors, including hepatocellular carcinoma. Clinically, the frequency of MDSCs is closely linked to the prognosis and predictive biomarkers of HCC patients, as well as the effectiveness of immune checkpoint inhibitors and tyrosine kinase inhibitors.

CANCERS (2021)

Add to Collection

Review Oncology

Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions

Xiao-Wan Bo et al.

Summary: Hepatocellular carcinoma is a common and deadly cancer, with thermal ablation being an important treatment option for patients who are not eligible for surgery or liver transplantation. Despite rapid advancements in TA technology, recurrence rates remain high, making immunotherapy a promising method to reduce tumor recurrence. The combination of local TA and systemic immunotherapy may be ideal for enhancing treatment efficacy and controlling recurrence.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Add to Collection

Review Cell Biology

Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment

Christina H. Stuelten et al.

Summary: TGF-beta plays a dual role in tumors, acting as an inhibitor of early-stage tumorigenesis while promoting late-stage tumor progression and metastasis. Through its ability to alter cell differentiation, TGF-beta induces transitions of various cell types, contributing to the progression of epithelial tumors.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Review Immunology

Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade

Amber G. Bozward et al.

Summary: Despite advancements in immunotherapy, treating HCC remains challenging. Research is needed to develop novel NK cell-targeted immunotherapy and control Treg frequency and function in HCC. Combining GMP-NK cell immunotherapy with CPI targeting NK and CD8 T cells may offer a promising therapeutic option.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Oncology

The Multifaceted Role of TGF-β in Gastrointestinal Tumors

Fabio Sabbadini et al.

Summary: TGF-beta acts as a tumor suppressor in early stages of cancer, but promotes tumor progression in advanced stages by modifying the tumor microenvironment and facilitating paracrine interactions between cells. Due to its critical role in cancer development and progression, there are ongoing efforts to develop molecules targeting the TGF-beta signaling pathway in various diseases.

CANCERS (2021)

Add to Collection

Review Oncology

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?

Ester Gonzalez-Sanchez et al.

Summary: TGF-beta signaling plays a dual role in HCC, acting as a tumor suppressor at early stages but promoting progression later on. It can also impact the tumor microenvironment and drive immune evasion of cancer cells. Targeting the TGF-beta pathway may be an effective therapeutic option for HCC, but biomarkers are crucial for patient selection.

CANCERS (2021)

Add to Collection

Review Immunology

Top 10 Challenges in Cancer Immunotherapy

Priti S. Hegde et al.

IMMUNITY (2020)

Add to Collection

Article Oncology

Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis

Yaqing Zhang et al.

CANCER DISCOVERY (2020)

Add to Collection

Review Cell Biology

Tumor microenvironment complexity and therapeutic implications at a glance

Roghayyeh Baghba et al.

CELL COMMUNICATION AND SIGNALING (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Immune-based therapies for hepatocellular carcinoma

David J. Pinato et al.

ONCOGENE (2020)

Add to Collection

Review Immunology

Cancer immunotherapy with γδ T cells: many paths ahead of us

Dieter Kabelitz et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Review Medicine, Research & Experimental

Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies

Yun Liu et al.

THERANOSTICS (2020)

Add to Collection

Review Immunology

Transforming Growth Factor-β Signaling in Immunity and Cancer

Eduard Batlle et al.

IMMUNITY (2019)

Add to Collection

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Add to Collection

Article Oncology

Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma

Bettina Langhans et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

Add to Collection

Review Medicine, General & Internal

Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies

Antonio Gnoni et al.

MEDICINA-LITHUANIA (2019)

Add to Collection

Article Multidisciplinary Sciences

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

Daniele V. F. Tauriello et al.

NATURE (2018)

Add to Collection

Article Oncology

gamma delta T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factors

Wei Tian et al.

ONCOLOGY LETTERS (2018)

Add to Collection

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Add to Collection

Review Oncology

Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives

Gael S. Roth et al.

EUROPEAN JOURNAL OF CANCER (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment

Sadna Budhu et al.

SCIENCE SIGNALING (2017)

Add to Collection

Article Cell Biology

TGF-β Family Signaling in Tumor Suppression and Cancer Progression

Joan Seoane et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Add to Collection

Review Oncology

Role of tumor microenvironment in tumorigenesis

Maonan Wang et al.

JOURNAL OF CANCER (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment

Sadna Budhu et al.

SCIENCE SIGNALING (2017)

Add to Collection

Article Cell Biology

Hepatocellular Carcinoma Cells Induce Regulatory T Cells and Lead to Poor Prognosis via Production of Transforming Growth Factor-beta 1

Yi Wang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)

Add to Collection

Article Cell Biology

Structural Biology and Evolution of the TGF-β Family

Andrew P. Hinck et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

Add to Collection

Article Cell Biology

TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology

Masato Morikawa et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

Add to Collection

Article Oncology

The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma

Fei Ji et al.

BMC CANCER (2015)

Add to Collection

Article Oncology

High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib

Tzu-Hsuan Lin et al.

CLINICAL CANCER RESEARCH (2015)

Add to Collection

Article Medicine, General & Internal

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

Claudia Allemani et al.

LANCET (2015)

Add to Collection

Review Cell Biology

Transforming Growth Factor Beta Family: Insight into the Role of Growth Factors in Regulation of Fracture Healing Biology and Potential Clinical Applications

Lukasz A. Poniatowski et al.

MEDIATORS OF INFLAMMATION (2015)

Add to Collection

Article Oncology

Low Counts of γδ T Cells in Peritumoral Liver Tissue are Related to More Frequent Recurrence in Patients with Hepatocellular Carcinoma after Curative Resection

Xiao-Yan Cai et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Add to Collection

Review Medicine, Research & Experimental

TGF-β - an excellent servant but a bad master

Lenka Kubiczkova et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2012)

Add to Collection

Review Physiology

Biological significance of local TGF-beta activation in liver diseases

Hiromitsu Hayashi et al.

FRONTIERS IN PHYSIOLOGY (2012)

Add to Collection

Review Biochemistry & Molecular Biology

TGFβ in cancer

Joan Massague

CELL (2008)

Add to Collection

Review Oncology

Role of transforming growth factor-β signaling in cancer

MP de Caestecker et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.